Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
OneTwenty AG logo — Groundbreaking diabetes intelligence technology and AID algo...

OneTwenty AG

Groundbreaking diabetes intelligence technology and AID algorithms

Founded 2022 Switzerland Zurich, Switzerland 6 employees Seed

General Information

Company Name OneTwenty AG
Founded Year 2022
Location Switzerland Zurich, Switzerland +1
Employees 6
Funding Stage Seed
Social

Get notified when OneTwenty AG moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About OneTwenty AG

OneTwenty AG, founded in 2022 in Switzerland, is making strides in the healthtech space with its innovative diabetes management solution. Their slogan, "Groundbreaking diabetes intelligence technology and AID algorithms," encapsulates their mission to revolutionize diabetes care.

The company has developed an app that uses deep learning to predict blood glucose levels 120 mins in advance, providing clinically safe accuracy. This service empowers individuals with actionable insights, aimed at reducing unhealthy glucose fluctuations.

Recently, OneTwenty AG secured an Early VC investment on 01 January 2024 from notable investors, including Brinc, Tiny Supercomputer Investment Company, and Tim Juergens. This funding will bolster their capacity to further refine their technology and expand their market reach.

Taxonomy: diabetes management, blood glucose prediction, deep learning, metabolic care, healthtech, digital health, interoperable glycemic control, sensor optimization, biomarker prediction, glucose regulation, personalized healthcare, clinical safety, AI in healthcare, glycemic control algorithms

Services & Products

bioX® Technology
Newton i/O Platform
Connected Insulin Pumps
Digital Twin Engine
Sensor Optimization

Target Customers

People with Diabetes Healthcare Providers Medical Technologists Insulin Therapy Patients

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Early VC •••••• 3
Investor
•••• •••• 		01 Jan 2024

OneTwenty AG Alternatives & Competitors

View All Alternatives
OneTwenty AG vs
GlucoSet
GlucoSet Norway

Intensive care monitoring

Unknown
16 employees
Biotechnology, Health Care
OneTwenty AG vs
HYGIEIA
HYGIEIA

Enhancing insulin therapy with personalized recommendations for improved glycemic control through a...

Series B
11-50 employees
Biotechnology, Health Care
OneTwenty AG vs
Portal Diabetes, Inc.
Portal Diabetes, Inc. United States

Freedom for people who use insulin.

Corporate Round
17 employees
Biotechnology, Health Care
View all alternatives

FAQ About OneTwenty AG

Groundbreaking diabetes intelligence technology and AID algorithms
OneTwenty AG was founded in 2022.
OneTwenty AG is headquartered in Zurich, Switzerland.
OneTwenty AG has approximately 6 employees.
OneTwenty AG has completed 1 funding round. The latest funding stage is Seed.
OneTwenty AG offers: bioX® Technology, Newton i/O Platform, Connected Insulin Pumps, Digital Twin Engine, Sensor Optimization.
Top alternatives and competitors to OneTwenty AG include GlucoSet, HYGIEIA, Portal Diabetes, Inc., OneTwo Analytics, Intuity Medical, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
OneTwenty AG and GlucoSet are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors OneTwenty AG and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy